Othram Funding: How Much Did They Raise & Key Investors

How Much Did Othram Raise?
Funding & Key Investors

Othram has successfully secured a major strategic investment, marking a significant milestone in its operational trajectory. With a total funding amount reaching $18.2M, the company continues to solidify its position as a leader in forensic biotechnology. This recent capital injection of $18M underscores the growing market confidence in the firm's proprietary DNA sequencing capabilities and its critical role in modernizing forensic evidence analysis for law enforcement and medical examiners globally.

The company's growth trajectory, characterized by a transition from early-stage development to enterprise-level scaling, reflects a robust demand for high-precision genetic analysis. By leveraging this latest financing, Othram is well-positioned to expand its laboratory infrastructure and enhance its technical throughput, ensuring that it remains at the forefront of the forensic science sector.

What is Othram?

Othram

Business Services

Research & Development

Healthcare Services

Founded in 2018 and headquartered in The Woodlands, Texas, Othram operates the world's first private DNA laboratory specifically engineered to apply modern parallel sequencing to forensic evidence. The company specializes in the recovery, enrichment, and analysis of human DNA from trace, degraded, or contaminated materials—a domain where traditional methods frequently encounter limitations. By bridging the gap between academic research and practical forensic application, Othram provides essential services to law enforcement agencies, medical examiners, and forensic scientists. Its market position is defined by its unique ability to deliver actionable intelligence in cold cases and complex criminal investigations where conventional forensic approaches have historically failed.

How much funding has Othram raised?

Othram has raised a total of $18.1M across 2 funding rounds:

2020

Debt

$150K

2021

Angel/Seed

$18M

Debt (2020): $150K with participation from PPP

Angel/Seed (2021): $18M led by Gigafund 0

Key Investors in Othram

Gigafund

Gigafund is a venture capital firm that invests in ambitious and transformative entrepreneurs across various sectors and stages, focusing on long-term concentrated investments to maximize impact over decades.

PPP

Public-Private Partnership

What's next for Othram?

Looking ahead, Othram is poised to leverage its recent strategic investment to accelerate the adoption of its forensic sequencing platform across broader jurisdictions. The company's roadmap likely includes scaling its proprietary enrichment protocols and expanding its collaborative network with academic and government institutions. As the demand for advanced genetic identification tools continues to rise, Othram's focus on high-throughput, high-accuracy analysis will be instrumental in setting new industry standards. The firm is expected to prioritize operational efficiency and technological refinement, ensuring that its forensic solutions remain the gold standard for solving complex cases that require the highest level of genetic resolution.

See full Othram company page

See More Financial Insights